Skip to Main Content

Paper Details

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Invest New Drugs
22
2019
ATP, BM, BRAF, BRAF V600E, BRAF V600E mutant, BRAF V600E mutant melanoma cell lines, BRAF-mutant, BRAF-mutant MM, E6201, MEK1, MM, Malignant melanoma, V600E, brain metastases, metastatic MM, metastatic malignant melanoma, patient, patients, tumor
Author NameAffiliation
Sara A ByronTranslational Genomics Research Institute
Winnie S LiangTranslational Genomics Research Institute
Daniel D Von HoffTranslational Genomics Research Institute
Daniel D Von HoffHonor Health Research Institute
John D CarptenTranslational Genomics Research Institute
David W CraigTranslational Genomics Research Institute
  • 1 - 6

Datasets

Release 1.2